Pharmacists in Lake Providence, LA Accepting Medicare
4 Pharmacists found. Showing 1 - 4
 Amanda Thornton Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 303 N Hood St, Lake Providence, LA 71254 Phone: 318-559-2433 Fax: 318-559-2437 |
Mary Catherine Coon, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 405 Lake St, Lake Providence, LA 71254 Phone: 318-559-2400 Fax: 318-559-3468 |
Brittany Nicole Shelton Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 302 Lake St, Lake Providence, LA 71254 Phone: 318-559-2433 |
Bobbie Stephens, PST.024041 Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 302 Lake Street, Lake Providence, LA 71254 Phone: 318-559-2433 |
News Archive
IRIN examines maternal mortality in Nepal
IRIN examines maternal mortality in Nepal, writing, "Observed declines [in the maternal mortality ratio (MMR)] since the early 1990s make Nepal, together with Bangladesh, the most recent 'success story,' comparable to countries like Malaysia, Thailand and Cuba that gained ground decades earlier, Julia Hussein, lead author of a 2011 medical appraisal of Nepal's MMR reduction, told IRIN."
Raptor Pharmaceuticals announces positive results for Convivia program
Raptor Pharmaceuticals Corp. has announced positive results in its Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.
Sinovac Biotech receives Drug Registration Certificate for seasonal influenza vaccine
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that Sinovac Biotech (Hong Kong) Ltd., its wholly owned subsidiary company in Hong Kong, has received the Certificate of Drug/Product Registration from the Hong Kong Department of Health for its seasonal influenza vaccine Anflu.
Combining PD-1 and VEGF inhibitors with chemotherapy can help control cholangiocarcinoma
Cholangiocarcinoma (CCA) is considered as a diverse group of epithelial cancers characterized by poor outcomes. Cholangiocarcinoma can be divided into three types according to the original position: Intrahepatic Cholangiocarcinoma (ICC), Perihilar Cholangiocarcinoma (PCC), and Distal Extrahepatic Tumors (DET).
ACTIONED consortium aims to transform future treatment of colorectal cancer patients
The Precision Medicine Centre of Excellence (PMC) at Queen's is leading a ground-breaking collaboration with the world's largest biotech company Roche, and Artificial Intelligence (AI) specialist, Sonrai Analytics.
› Verified 1 days ago